In 2006 the Sacramento Angels led the initial financing round for Idapted. Idapted was founded by two students from Stanford to create a business and technology platform to enable people worldwide to learn English with VOIP technology and one-on-one tuition by home base tutors working remotely. It’s initial focus was the market for learning English in China and the company moved there and obtained its next round of venture capital funding from Gobi Partners.
The Sacramento Angels released this to the press today.
Sacramento Angels go “Back to School” in a September Network Event at the UC Entrepreneurship Academy
August 30, 2010. The Sacramento Angels, an accredited group of investors in the Sacramento Valley region, will host a major event on September 15 at the UC Davis Conference Center, bringing together faculty, industry executives, Sacramento Angels and individual investors from the region to the fifth annual UC Entrepreneurship Academy.
Members of our group participated in the Cloud Cruiser Series A Venture Capital round led by Wavepoint Ventures. Wavepoint is a Corporate member of the Sacramento Angels.
Cloud Cruiser’s is currently in stealth mode and is developing unique solutions to address the growing pain of both cloud service providers and enterprises that are implementing virtualization and cloud computing infrastructure. The company has its origins locally in Roseville.
Take a look at the full press release.
The Sacramento Angels, together with the Sierra Angels, led a multi-million dollar financing for San Francisco web annotation startup company, Reframe It. They were joined by other regional angel groups and individual angels. You can read the web press release here, and see another report of the financing gathered, in part, from the filing with the SEC of Form D here.
VinPerfect won the 2008 UC Davis Big Bang Business Plan competition and the Sacramento Angels have added the company to its portfolio of investments.
VinPerfect offers a high-performance screw cap closure with a liner that allows winemakers to specify how much oxygen enters a wine bottle over time and, therefore, how their wine ages. The company will use the investors’ money to buy equipment and authenticate its package design and reliability.
Read the story here.
Four years ago, at least two of our current and former members invested in NovaCal, developer of a very promising anti-microbial. It has changed its name to NovaBay Pharmaceuticals and secured an important strategic relationship with Alcon for eyecare products. It went public late last year. It is now traded on the Amex under the symbol NBY. The IPO price of $4.00 is reported to be 3.2X the adjusted investment price. For more information see the company website. Congratulations to those who could see the opportunity!